your Good joining Ori. morning, we you, everyone, us. appreciate Thank and
wearable of FDA production, achievements program robotic ReStore milestone system stroke patients. shipment soft stroke of with the initiation CE and clearance, and The activities delivery first of second for the quarter had successful sales for
of the unique a coming disruptive in substantial much company it growth Broadening be in and for foundation objective of three its past has key larger a been market years. a the technology company of revenue and years, commercialization into strategic the will and basis the with second the over the
Our this the quarter, the will expand many spinal SCI, with States. until and deferred product we ReWalk sales sales until in expected spinal an United coverage injury, uneven cord of the The finalize remain German July. injury line had cord pattern or our product with choppy QX reimbursement contracts payers
our second can where have continuing management, and runway the with we strengthened financial potential established quarter Importantly, have demonstrate fundraising we and our balance offering. a growth of the expense and sheet
detail clearances our and we on Next, CE May the stoke SCI ReStore our and revenue. and exo-suit on to I provide more on June X, XX ReStore, activities want QX FDA ReWalk received With respectively.
in ready to commercial our were clinics. products to XX, allowed stroke warehouse which us demonstrations initiate on first Our June
in six have demonstrations therapists first patients the multiple XX system. Over accounts sevenhands-on XX presented the XX and with United weeks, to XX and States hands-on the accounts with XX we the EU in involving in patients with to demonstrations
step in that to propulsion learned believe improved first of XXX from as it in sales currently for clinical the necessary providing to the assistance A is these have forward interactions. We the technology demonstration Simply, deal it. a to process succeeded they great targeted is this need ankle. plantarflexion account a has see
is clinical leasing from budget. through the XX-plus of are that operating for to time an acceptance order cycle expect We issuance accounts days a purchase
defined equipment, the it capital budget clinics' For is by cycles. more
the need, found particularly of the high demonstrations in value clinics. level clinical and We have of in hands-on XX the acceptance a
consideration centers. We financial the from and segments a also that outcomes understand these and require of purchase obtaining solid orders value will business economic
our main in pipeline Of is had the placements note that date. goals. we We to the systems and diverse stream are match placed have building solid have a United three States
Burkettsville, first for Neurological stroke include and as for placement have free placement Barrow's Development leader and in at the systems in national is XX Center which years; sizable have for Japan Neurological they adults rehab; services a population. in The children for which Phoenix, Ohio, Institute a at provided therapeutic
clients were that walking in sponsor instantly XX from The the experience. and had the client walking following on gait. Ohio, Burkettsville, DJ unit the how We easy. improve their a their feedback for changer This improved absolutely for try use her We she abilities, Westride, that wish post-stroke we spot." the are when device "Learning unit was over quite astonished about purchased comment the that is the game going a made encouraged to more and to on this clinical the builds the We is the time forward unit. clinical a Longer and was interest actually our directly years on we of to studies our for with first published cycle be clinics in convert insurers transactions, weeks. rather broader pathway patients. building placements six account than essential our trial for By Harvard have capacity predictable the The building the decision market. into success process. working term, will data the and these key treatment scientific measurement in our
Commission [ph]. that to Our focus of Joint by multiple national private satellites has outpatient XXX centers go-to-market needs. X,XXX targets, these started centers. are XX to and groups. rehab Germany targets XX United well-defined meet most to and And with targets centers health are Each large attached will their XXX centers. The service U.K. German The realistic inpatient Healthcare are are rehab are that The these acquire there initial the include U.K. systems and additional approximately targets States, certified centers Organizations U.S. in consist on the and the of are enough
functionality et and the Harvard's the and importance reviews, recovery this results rehabilitation one activity-specific improving techniques, the the functional matches This These mobility of Roker, supporting treating gait & AHA, three of design data with stroke demonstrated function elements in ReWalk such al, value therapy primary at Association's, other to for of groups enabling post-stroke papers including publication the published by value outcomes. technology Institute, documenting continued outcomes in for The highlight plantarflexion Gait and its system. publications in practice proposition the of for targeting for Wyss of of the on The patients' for unique exo-suit testing Posture key February in as these Heart the role sessions papers, the are patient business along consists The rehabilitation XXXX. clinics' technology is coverage of review their ability patients. value and additional this justification S.A. by business American guidelines new facilitate ReStore insurance of and progress.
includes clinical clinical staffing due use, and the therapists to and technology patient to ReStore of reliable planned due in are coming technology the papers Additional data the publications sessions requiring the technique fewer allocations improved more therapy trial Company-sponsored the describing improved benefits ReStore white as of attendance of as multiple value months. well submissions patient engagement. for
also clinical studies progress Additional trial. several at sites are in from clinical the
profile, As an XX% place each estimate moderate of have once from we approximately changed we additional of cycles parts price liners unit consider two planned year the disposables: We purchase based in have clinic. revenue six have system, months. patterns on usage to every approximately of or to revenue every XXX,XXX that use by cables patient drive three the a device the in addition we to cables. provided are initial and each The the the for
to customer pleased these over we with Overall, six the very system weeks. are reaction the first
many have forward. are confirmed we moving market and understanding and the required system areas our We emphasis of what about and function, assumptions adjustments are of
in close In results placements the and cord injury the conversion. Next, weeks QX left the received QX with as number let's these first the us pending concluded by quarter, as a July, that we had of we the not we expected spinal end of to of of QX systems were the lower-than-expected examine completed already until trends. of with orders Globally, five end third $XXX,XXX June cases market achieved which many at already have revenue. $XXX,XXX $XXX,XXX, their delivered, recognized of
for and have contracts OP&R insurers The of MDK caused that insurance were was nine delays the the to commissions that body or pace primary disputes by had contracts decisions. a on units units many but qualification, in with EU lower that placements reason were rentals we governing as of with XXXX, we the quarter. For QX between In and we the completing patient Shops in insurers. revenue long convert operating this three not as are EU, pending insurers. Presently, new XXXX performs QX, in a placed trial of and and assessments had pending on the cycle QX June key currently in total solid XX able
pending pipeline. targeted patients in complete We second the two at have expect half groups to our within XX of XXXX. These least
second U.S. authorizations ReWalks who placed payers private units U.S. still recognized quarter. QX. is three thus reviews placed the approved We confirmed the and with XX, for additional final based the at and not We in placement insurance start four were case-by-case on by was had June pricing unpredictable. The of remain where during
XXXX, believe the the the encouraged that And we we XXXX. equivalent already mostly to we're under patient of fact number it by have have still because the decisions full is is insurance made the Although shift are year Act. which numbers Care Affordable low, had sevenpositive we in of the we in appeals
in their completes forward, intent of Each QX. VA units has from these publish ReWalks Cigna to study policy look randomized patients, we expect available we the As more their updated additional stated their users. to make as and
to I'll review financial our results. that, Ori Ori? call With the turn to over
